Elkholy, M. M., Fahmi, M. W., & El‐Haggar, S. M. (2022). Dynamic changes in the levels of sCD62L and SPARC in chronic myeloid leukaemia patients during imatinib treatment. Journal of clinical pharmacy and therapeutics, 47(12), 2115-2129. https://doi.org/10.1111/jcpt.13759
Chicago Style (17th ed.) CitationElkholy, Mahmoud Mohamed, Maryan Waheeb Fahmi, and Sahar Mohammed El‐Haggar. "Dynamic Changes in the Levels of SCD62L and SPARC in Chronic Myeloid Leukaemia Patients During Imatinib Treatment." Journal of Clinical Pharmacy and Therapeutics 47, no. 12 (2022): 2115-2129. https://doi.org/10.1111/jcpt.13759.
MLA (9th ed.) CitationElkholy, Mahmoud Mohamed, et al. "Dynamic Changes in the Levels of SCD62L and SPARC in Chronic Myeloid Leukaemia Patients During Imatinib Treatment." Journal of Clinical Pharmacy and Therapeutics, vol. 47, no. 12, 2022, pp. 2115-2129, https://doi.org/10.1111/jcpt.13759.